Utility of [ <sup>18</sup> F]PI-2620 as Universal Biomarker for the Amyloid/Tau/Neurodegeneration Classification of Alzheimer Disease: An Exploratory Study with Dual-Phase PET Imaging
Analysis of AD and normal controls suggests a potential role of [<sup>18</sup>F]PI-2620 as a single biomarker for the A/T/N classification.
Authors
- Marc L. Gordon (ORCID: https://orcid.org/0000-0001-6277-2338)
- Jorge Irias Banegas
- Shichun Peng (ORCID: https://orcid.org/0000-0003-0653-636X)
- Yilong Ma
- Ana M. Franceschi
- Graham Keir
Institutions
- Feinstein Institute for Medical Research (US)
- Lenox Hill Hospital (US)
- Piedmont Atlanta Hospital (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
Publication Details
- Journal
- American Journal of Neuroradiology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.3174/ajnr.a8980
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00